The COVID-19 epidemic is impacting every area of doing business, including Intellectual property. Weintraub IP attorneys are monitoring the impacts of COVID-19 on intellectual property issues, including patent, trademark, and copyright. If you have questions or need assistance, contact our Intellectual Property Group.
If you would like to be made aware when a new blog post, article, or resource related to the COVID-19 pandemic is published by attorneys at Weintraub Tobin, you can sign up here to receive an email notification.
To view all resources in chronological order instead of by topic, click here.
We will collect blog posts, articles, and webinars addressing IP issues related to COVID-19 here:
Pfizer and BioNTech recently asked the Southern District of California to dismiss a patent infringement claim from Allele Biotechnology related to Pfizer and BioNTech’s Covid-19 vaccine. Allele holds a patent…
Weintraub attorney Jessica Corpuz hosted a one-hour webinar about Intellectual Property Law and will specifically address The Consolidated Appropriations Act of 2021. A recording of this webinar can be viewed…
The United States Patent and Trademark Office has established a new program for prioritized examination for patent applications for inventions related to COVID-19 and for trademark applications for marks used…
On March 31, 2020, the U.S. Patent and Trademark Office announced that, pursuant to the Coronavirus Aid, Relief, and Economic Security Act, certain deadlines for patent and trademark applications would…
Call me a pessimist, but it was surprising to me when I recently checked the USPTO trademark database that I did not find an application to register “Social Distancing” for…
